9 research outputs found

    <i>Sod1</i> expression in mouse brain.

    No full text
    <p>Panel A and B. Quantification of <i>Sod1</i> mRNA expression in whole brain by real-time RT-PCR. N = 6 for all groups and samples were run in triplicate. All samples were duplexed for <i>Sod1</i> (Fam-label) and an endogenous control <i>GAPDH, β-actin</i> or <i>Thy-1</i> (Vic-label). Expression level is expressed in arbitrary units as normalised by the geometric mean of the quantity of the endogenous controls (<i>y</i>-axis). Error bars represent the standard deviation. (A) <i>Sod1</i> mRNA expression level for parental strain of the HS mice (except LP). (B) <i>Sod1</i> mRNA expression level grouped by allele (A/G) (A = A, BALB, C3H, C57; G = AKR, CBA, DBA). No significant difference was observed between the groups. Panels (C) and (D). Quantification of Sod1 protein in whole brain (10% homogenate, weight/volume) from n = 3 A allele mice (C57Bl/6) and G allele mice (FVB/N). FVB/N mice were used to represent a G allele strain rather than an HS parental strain due to availability of tissue. Samples were immunoblotted with rabbit polyclonal anti-human SOD1(Abcam) and detected with IRDye800CW (green) conjugated goat anti-rabbit IgG (Li-Cor). Anti-β-actin mouse monoclonal antibody (Sigma) was also included as a loading control and was detected using IRDye680 (red) conjugated goat anti-mouse IgG (Li-Cor). Fluorescence was visualised using an Odyssey infra-red imager (Li-Cor). (C) Uninoculated mice, (D) Terminally sick Chandler/RML prion inoculated mice.</p

    Kaplan-Meier survival curves.

    No full text
    <p>Data are shown as % of animals (female) surviving (y-axis) plotted against the number of days post inoculation (x-axis). (A) Transmission of Chandler/RML prion strain to <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT) litter mate controls (B) Transmission of ME7 prion strain to <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT). (C) Transmission of MRC2 mouse adapted BSE prion strain to <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT). A reduction in mean incubation time of 20%, 13%, and 24% was seen in A-C respectively. This reduction in survival was statistically significant for each transmission (P<0.001, Kaplan-Meier log-rank survival test).</p

    Western blots of PrP<sup>Sc</sup> from infected mouse brains.

    No full text
    <p>10% w/v brain homogenates (n = 3 per group) were digested with proteinase K and immunoblotted with anti-PrP monoclonal antibody ICSM35 (D-Gen Ltd, UK). (A) Transmission of Chandler/RML prions to <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT) litter mate controls. (B) Transmission of ME7 prion strain to <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT) litter mate controls. (C) Transmission of MRC2 mouse adapted BSE prion strain to <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT) litter mate controls. No differences were seen between the two groups regardless of prion strain.</p

    SNP genotyping in HS mice.

    No full text
    <p>Genomic location is given based on mouse genome assembly NCBI build 37. Details of the <i>Sod1</i> and <i>Il1-r1</i> SNPs are available from the Sanger Centre (<a href="http://www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl" target="_blank">www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl</a>). All polymorphisms were analysed by allele discrimination using a 7500 Fast real time PCR system (Applied Biosystems). For probe details see Table S1. For all genotypes, the statistical test used was the Kruskal-Wallis non-parametric ANOVA. The allelic test used was the Mann-Whitney test.</p

    Quantification of Sod and PrP<sup>C</sup>

    No full text
    <p>. 10% weight/volume brain homogenates immunoblotted with rabbit polyclonal anti-human SOD1 (Abcam) and detected with IRDye800CW (green) conjugated goat anti-rabbit IgG (Li-Cor). Anti-β-actin mouse monoclonal antibody (Sigma) was also included as a loading control and was detected using IRDye680 (red) conjugated goat anti-mouse IgG (Li-Cor). Fluorescence was visualised using an Odyssey infra-red imager (Li-Cor). (A) Brains from <i>Sod1<sup>+/+</sup></i> wild type mice inoculated with PBS compared with end stage Sod1<sup>+/+</sup> wild type mice inoculated with RML, ME7 and MRC2 prion strains. No differences were seen between the groups. (B) Uninfected mice. (C) Total SOD enzymatic activity in 10% (w/v) <i>Sod1<sup>+/+</sup></i> (WT) brains. Brains from terminally sick mice infected with RML, ME7 and MRC2 were compared with uninfected mice. Samples were run in triplicate with n = 6 for each group. Data are shown normalised by total protein content (µg/ml) as determined by a Bradford protein assay (mean ± standard deviation). No significant difference was seen between the groups. (D) PrP<sup>c</sup> levels in <i>Sod1<sup>−/−</sup></i> and <i>Sod1<sup>+/+</sup></i> (WT) litter mate control mice by ELISA. PrP<sup>c</sup> levels (µg/ml) were determined in triplicate using 10% (weight/volume) brain homogenate for <i>Sod1<sup>−/−</sup></i> (n = 3) and <i>Sod1<sup>+/+</sup></i> (n = 3) in a PrP specific ELISA <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0054454#pone.0054454-Wadsworth2" target="_blank">[32]</a>. Data are shown normalised by total protein content (µg/ml and x 1000) as determined by a BCA assay (mean ± standard deviation). No significant difference was seen between the two groups.</p

    Major strain distribution patterns genotyped for HS mice.

    No full text
    <p>The number of SNPs is taken from genomic sequence generated by the Sanger Institute (<a href="http://www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl" target="_blank">www.sanger.ac.uk/cgi-bin/modelorgs/mousegenomes/snps.pl</a>) and spans 5 kb upstream of the 5′UTR start site to the end of the 3′UTR (NCBI Build 37). Ambiguous SNPs have been excluded. The strain distribution pattern (BALB, CBA); (A, AKR, C3H, C57, DBA, LP) was also seen for <i>App</i> (239/978) but this was not genotyped in the HS mice. Other individual strain distribution patterns were seen ≤5 times.</p

    RML histology.

    No full text
    <p>Histological features of Chandler/RML prion transmission to <i>Sod1<sup>−/−</sup></i> (A–C) and wild type control (D–F) mice. Panels A and D show distribution of disease-associated PrP by immunohistochemistry using anti-PrP monoclonal antibody ICSM35. Panels B, C, E and F show detail from the hippocampus and are stained with haematoxylin and eosin (H&E) to visualise spongiform change and neuronal loss. There is almost no neuronal loss in the <i>Sod1<sup>−/−</sup></i> mice but mild neuronal loss is seen in the wild type animals. Overall, the pattern of spongiosis, gliosis and PrP distribution are similar between the two groups, however, the distribution of disease-associated PrP is patchier in the knockouts especially in the cortex. Scale bar corresponds to 3 mm (A, D), 660 µm (B, E) or 160 µm (C, F).</p

    Marketing Strategy Proposal for "sKým.cz Services

    No full text
    This diploma thesis creates marketing strategy for the starting web project- sKým.cz. In the first part, I am presenting general knowledge necessary for understanding the issues of marketing strategy. The next part contains analysis of current market situation. The output of the diploma thesis are proposals of marketing strategy for project Ským.cz. These proposals are meant to increase the market share and the overall profitability of the project

    COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19

    No full text
    The COVID-19 pandemic continues to pose a major public health threat, especially in countries with low vaccination rates. To better understand the biological underpinnings of SARS-CoV-2 infection and COVID-19 severity, we formed the COVID-19 Host Genetics Initiative1. Here we present a genome-wide association study meta-analysis of up to 125,584 cases and over 2.5 million control individuals across 60 studies from 25 countries, adding 11 genome-wide significant loci compared with those previously identified2. Genes at new loci, including SFTPD, MUC5B and ACE2, reveal compelling insights regarding disease susceptibility and severity.</p
    corecore